Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emmessar Biotech & Nutrition Ltd has informed BSE that the trading window for dealing in its securities will be closed from April 1, 2026, until 48 hours after the company's financial results for the quarter and financial year ending March 31, 2026 become publicly available. This is a routine compliance filing made under SEBI's Prohibition of Insider Trading Regulations, 2015. No specific insider trading transaction or acquisition is disclosed in this filing.
This is a standard regulatory intimation and not an actionable corporate event. The window closure simply means insiders, directors, and connected persons cannot trade in the stock until results are announced, which is normal ahead of quarterly and annual results.